Food and Beverage
NeurogesX Shares Rise Following FDA Approval
NEW YORK (AP) — Shares of biotechnology company NeurogesX Inc. jumped Tuesday after the company received Food and Drug Administration approval for its Qutenza pain patch.
The stock rose 51 cents, or 6.2 percent, to $8.75 in afternoon trading. Shares have traded between 89 cents and $9.20 over the last 52 weeks. The FDA approved Qutenza as a treatment for postherpetic neuralgia, a type of nerve pain condition that results from shingles. The company plans to launch the drug in the U.S. in the first half of 2010. The patch is already approved in Europe for peripheral nerve pain in non-diabetic adults. Lazard Capital Markets analyst William Tanner reaffirmed a "Buy" rating and $9 price target, saying the approval seemed likely. He forecast sales of $88 million in 2011, which will also likely be the company's first profitable year. U.S. sales could peak over $350 million annually by 2015.TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn MoreTo begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,393.45 | 1,310.33 | 2,827.34 | 15.81 |
Oil *
101.78
|
|
DOWN
26.41 |
DOWN
2.99 |
DOWN
10.02 |
DOWN
0.44 |
10 Yr
1.58%
SPDR Gold
151.62
|
|
-0.21%
|
-0.23%
|
-0.35%
|
-2.71%
|
Data delayed 20 minutes |
Connect with TheStreet